INfluenza VaccInation To Mitigate typE 1 Diabetes

Recruiting Phase 4 Interventional Study
Diabetes Mellitus, Type 1
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
7 – 17
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Aarhus University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients hospitalized with newly diagnosed type 1 diabetes mellitus. * Written informed consent (parents, legal guardian). Exclusion Criteria: * Influenza vaccination during the current influenza season. * Strong indication for influenza vaccination for non-diabetic disease.…
Contacts

Ole Frøbert, MD, PhD

0046730895413

olefro@clin.au.dk

CONTACT

Mads F. Kjølby, MD, PhD

004560866653

mads@dandrite.au.dk

CONTACT